| JTH2200238 | 拉米夫定齐多夫定片 | lamivudine;zidovudine | Tablet | Chemical Drugs | Disposable Import Drug Application | 2022-12-21 | | | | | view |
| A20000012 | 拉米夫定口服溶液 | lamivudine | Oral solution | Chemical Drugs | Import Drug Application | 2000-01-01 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Approval Completed-Pending Certificated | | view |
| CYHB2450127 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2024-02-19 | | ZHONGFU Pharmaceutical Co Ltd | | | view |
| JYHZ2200095 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs | License Renew | 2022-04-07 | | | | | view |
| CYHS2403711 | 拉米夫定替诺福韦片 | lamivudine;tenofovir | Tablet | Chemical Drugs(3) | Generic Drug | 2024-11-01 | | Shijiazhuang Lonzeal Pharmaceuticals Co Ltd | | | view |
| JXHS2200055 | 依非韦伦拉米夫定替诺福韦片 | efavirenz;lamivudine;Tenofovir disoproxil fumarate | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2022-06-22 | | | | | view |
| CYHS2301701 | 拉米夫定替诺福韦片 | lamivudine;tenofovir | Tablet | Chemical Drugs(3) | Generic Drug | 2023-06-27 | | | | | view |
| JYHB2400183 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2024-04-26 | | | | | view |
| CYHS2200146 | 依非韦伦拉米夫定替诺福韦片 | efavirenz;lamivudine;Tenofovir disoproxil fumarate | Tablet | Chemical Drugs(3) | Generic Drug | 2022-01-21 | | Shanghai DESANO Biopharmaceutical Co Ltd | | | view |
| CYHB2250304 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs(原6) | Supplementary Application | 2022-06-01 | | Shanghai DESANO Biopharmaceutical Co Ltd | | | view |
| CYHB2301246 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs(4) | Supplementary Application | 2023-06-01 | | | | | view |
| JYHB2400159 | 拉米夫定多替拉韦片 | DOLUTEGRAVIR SODIUM;LAMIVUDINE | Tablet | Chemical Drugs | Supplementary Application | 2024-04-12 | | | | | view |
| JYHB2101631 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2021-12-31 | | | | | view |
| JYHB2300297 | 拉米夫定多替拉韦片 | DOLUTEGRAVIR SODIUM;LAMIVUDINE | Tablet | Chemical Drugs | Supplementary Application | 2023-05-22 | | | | | view |
| H20010150 | 拉米夫定原料 | lamivudine | Active ingredient | Chemical Drugs | Import Drug Application | 2001-06-20 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Approval Completed-Pending Certificated | | view |
| CYHB2450128 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2024-02-19 | | ZHONGFU Pharmaceutical Co Ltd | | | view |
| JXHS2101033 | 拉米夫定多替拉韦片 | DOLUTEGRAVIR SODIUM;LAMIVUDINE | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2021-07-16 | | | | | view |
| JYHS2300046 | 依非韦伦拉米夫定替诺福韦片 | efavirenz;lamivudine;Tenofovir disoproxil fumarate | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2023-04-01 | | | | | view |
| CYHB2450129 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2024-02-19 | | ZHONGFU Pharmaceutical Co Ltd | | | view |
| CYHS2201775 | 拉米夫定口服溶液 | lamivudine | Oral solution | Chemical Drugs(4) | Generic Drug | 2022-10-19 | | | | | view |
